Four infant monkeys were dosed orally with 500 μg Hg/kg body wt./day (as methylmercury (MeHg) chloride dissolved sodium carbonate) beginning at 1 day of age. Neurological and behavioral signs of MeHg toxicity and blood Hg levels were monitored weekly. At first sign of MeHg intoxication, dosing with MeHg was terminated and the infants were monitored to assess reversal of the signs of MeHg toxicity. The first signs of MeHg toxicity, exhibited as a loss in dexterity and locomotor ability, were observed after 28–29 days of treatment; the blood Hg levels were 8.0–9.4 μg Hg/g blood. Dosing was terminated at 28–29 days of treatment but the signs of MeHg toxicity continued to develop. The infants became ataxic, blind, comatose and were necropsied at 35–43 days after initiating treatment with MgHg. The mercury concentrations in tissues analyzed after necropsy were highest in liver (55.8 ± 3.2 μg Hg/g) followed by occipital cortex (35.6 ± 4.8 μg Hg/g) and renal cortex (32.8 ± 1.6 μg Hg/g). The frontal and temporal cortices had 27.0 ± 3.4 and 29.6 ± 4.9 μg Hg/g respectively while the cerebellar Hg concentration averaged 13.0 ± 1.5 μg Hg/g. The mean blood/brain ratio was 0.21 ± 0.4. Histopathologic lesions were marked in the cerebrum with less severe lesions in the cerebellar nuclei. The Purkinje and granular cells of the cerebellar vermis appeared histologically normal. Lesions were not observed in the peripheral nervous system. The signs of MeHg intoxication, the tissue distribution of MeHg and histopathologic lesions observed in the infant monkeys were similar to those reported for adult monkeys.
Read full abstract